Boston Scientific Corporation (BSX.F)
EUR 93.0
(4.49%)
EUR 93.0
(4.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.96 Billion USD | -3.25% |
| 2022 | 9.26 Billion USD | 0.78% |
| 2021 | 9.19 Billion USD | -3.53% |
| 2020 | 9.52 Billion USD | 7.5% |
| 2019 | 8.86 Billion USD | 85.49% |
| 2018 | 4.77 Billion USD | 26.48% |
| 2017 | 3.77 Billion USD | -30.31% |
| 2016 | 5.42 Billion USD | -4.48% |
| 2015 | 5.67 Billion USD | 47.03% |
| 2014 | 3.85 Billion USD | -8.92% |
| 2013 | 4.23 Billion USD | -0.35% |
| 2012 | 4.25 Billion USD | -0.12% |
| 2011 | 4.25 Billion USD | -13.72% |
| 2010 | 4.93 Billion USD | -16.58% |
| 2009 | 5.91 Billion USD | -12.28% |
| 2008 | 6.74 Billion USD | -15.0% |
| 2007 | 7.93 Billion USD | -10.82% |
| 2006 | 8.89 Billion USD | 377.2% |
| 2005 | 1.86 Billion USD | 63.65% |
| 2004 | 1.13 Billion USD | -2.82% |
| 2003 | 1.17 Billion USD | 38.37% |
| 2002 | 847 Million USD | -12.95% |
| 2001 | 973 Million USD | 69.51% |
| 2000 | 574 Million USD | -15.34% |
| 1999 | 678 Million USD | -50.29% |
| 1998 | 1.36 Billion USD | 2845.57% |
| 1997 | 46.3 Million USD | -1.91% |
| 1996 | 47.2 Million USD | 263.08% |
| 1995 | 13 Million USD | 46.07% |
| 1994 | 8.9 Million USD | 48.33% |
| 1993 | 6 Million USD | -1.64% |
| 1992 | 6.1 Million USD | -71.5% |
| 1991 | 21.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 9.35 Billion USD | -5.7% |
| 2024 Q1 | 9.91 Billion USD | 11.25% |
| 2023 Q4 | 8.96 Billion USD | 1.99% |
| 2023 Q1 | 8.85 Billion USD | -4.39% |
| 2023 Q3 | 8.78 Billion USD | -1.23% |
| 2023 FY | 8.96 Billion USD | -3.25% |
| 2023 Q2 | 8.89 Billion USD | 0.45% |
| 2022 Q3 | 8.91 Billion USD | -2.65% |
| 2022 Q4 | 9.26 Billion USD | 3.9% |
| 2022 FY | 9.26 Billion USD | 0.78% |
| 2022 Q1 | 9.44 Billion USD | 2.77% |
| 2022 Q2 | 9.15 Billion USD | -3.05% |
| 2021 Q1 | 9.43 Billion USD | -1.01% |
| 2021 Q2 | 9.2 Billion USD | -2.42% |
| 2021 Q3 | 9.19 Billion USD | -0.04% |
| 2021 Q4 | 9.19 Billion USD | -0.09% |
| 2021 FY | 9.19 Billion USD | -3.53% |
| 2020 Q1 | 9.59 Billion USD | 8.26% |
| 2020 FY | 9.52 Billion USD | 7.5% |
| 2020 Q4 | 9.52 Billion USD | 2.21% |
| 2020 Q3 | 9.32 Billion USD | -2.25% |
| 2020 Q2 | 9.53 Billion USD | -0.6% |
| 2019 Q2 | 7.57 Billion USD | 0.03% |
| 2019 FY | 8.86 Billion USD | 85.49% |
| 2019 Q3 | 9.57 Billion USD | 26.4% |
| 2019 Q4 | 8.86 Billion USD | -7.47% |
| 2019 Q1 | 7.57 Billion USD | 58.55% |
| 2018 FY | 4.77 Billion USD | 26.48% |
| 2018 Q1 | 4.76 Billion USD | 26.24% |
| 2018 Q2 | 4.77 Billion USD | 0.17% |
| 2018 Q3 | 4.77 Billion USD | 0.04% |
| 2018 Q4 | 4.77 Billion USD | -0.02% |
| 2017 Q3 | 4.41 Billion USD | -8.32% |
| 2017 FY | 3.77 Billion USD | -30.31% |
| 2017 Q4 | 3.77 Billion USD | -14.47% |
| 2017 Q2 | 4.81 Billion USD | -12.56% |
| 2017 Q1 | 5.5 Billion USD | 1.64% |
| 2016 Q1 | 5.42 Billion USD | -4.41% |
| 2016 FY | 5.42 Billion USD | -4.48% |
| 2016 Q3 | 5.17 Billion USD | -0.04% |
| 2016 Q2 | 5.17 Billion USD | -4.63% |
| 2016 Q4 | 5.42 Billion USD | 4.82% |
| 2015 Q3 | 5.79 Billion USD | 14.34% |
| 2015 Q4 | 5.67 Billion USD | -2.1% |
| 2015 FY | 5.67 Billion USD | 47.03% |
| 2015 Q1 | 3.84 Billion USD | -0.36% |
| 2015 Q2 | 5.06 Billion USD | 31.83% |
| 2014 Q4 | 3.85 Billion USD | -9.18% |
| 2014 Q2 | 4.25 Billion USD | 0.16% |
| 2014 Q3 | 4.24 Billion USD | -0.07% |
| 2014 FY | 3.85 Billion USD | -8.92% |
| 2014 Q1 | 4.24 Billion USD | 0.19% |
| 2013 Q1 | 4.25 Billion USD | -0.05% |
| 2013 Q4 | 4.23 Billion USD | -0.21% |
| 2013 Q3 | 4.24 Billion USD | 16.42% |
| 2013 Q2 | 3.64 Billion USD | -14.19% |
| 2013 FY | 4.23 Billion USD | -0.35% |
| 2012 Q3 | 4.25 Billion USD | -0.02% |
| 2012 Q2 | 4.25 Billion USD | -0.05% |
| 2012 Q1 | 4.25 Billion USD | -0.05% |
| 2012 FY | 4.25 Billion USD | -0.12% |
| 2012 Q4 | 4.25 Billion USD | 0.0% |
| 2011 Q1 | 4.67 Billion USD | -5.35% |
| 2011 FY | 4.25 Billion USD | -13.72% |
| 2011 Q4 | 4.25 Billion USD | -0.05% |
| 2011 Q3 | 4.25 Billion USD | 1.48% |
| 2011 Q2 | 4.19 Billion USD | -10.13% |
| 2010 Q3 | 5.13 Billion USD | -0.96% |
| 2010 Q2 | 5.18 Billion USD | -8.61% |
| 2010 Q1 | 5.67 Billion USD | -4.13% |
| 2010 FY | 4.93 Billion USD | -16.58% |
| 2010 Q4 | 4.93 Billion USD | -3.88% |
| 2009 Q2 | 5.92 Billion USD | -5.16% |
| 2009 Q4 | 5.91 Billion USD | -0.15% |
| 2009 FY | 5.91 Billion USD | -12.28% |
| 2009 Q3 | 5.92 Billion USD | 0.07% |
| 2009 Q1 | 6.24 Billion USD | -7.43% |
| 2008 Q4 | 6.74 Billion USD | -0.35% |
| 2008 FY | 6.74 Billion USD | -15.0% |
| 2008 Q1 | 7.31 Billion USD | -7.84% |
| 2008 Q2 | 7.01 Billion USD | -4.06% |
| 2008 Q3 | 6.76 Billion USD | -3.52% |
| 2007 FY | 7.93 Billion USD | -10.82% |
| 2007 Q4 | 7.93 Billion USD | 0.38% |
| 2007 Q1 | 8.89 Billion USD | 0.03% |
| 2007 Q2 | 8.25 Billion USD | -7.28% |
| 2007 Q3 | 7.9 Billion USD | -4.21% |
| 2006 FY | 8.89 Billion USD | 377.2% |
| 2006 Q1 | 1.83 Billion USD | -1.5% |
| 2006 Q2 | 8.89 Billion USD | 384.31% |
| 2006 Q3 | 8.89 Billion USD | 0.01% |
| 2006 Q4 | 8.89 Billion USD | 0.02% |
| 2005 Q1 | 1.11 Billion USD | -2.11% |
| 2005 Q3 | 2.43 Billion USD | 60.08% |
| 2005 Q2 | 1.51 Billion USD | 36.14% |
| 2005 Q4 | 1.86 Billion USD | -23.29% |
| 2005 FY | 1.86 Billion USD | 63.65% |
| 2004 Q1 | 611 Million USD | -47.87% |
| 2004 FY | 1.13 Billion USD | -2.82% |
| 2004 Q3 | 1.74 Billion USD | -1.25% |
| 2004 Q4 | 1.13 Billion USD | -34.54% |
| 2004 Q2 | 1.76 Billion USD | 188.38% |
| 2003 Q2 | 974 Million USD | 17.92% |
| 2003 FY | 1.17 Billion USD | 38.37% |
| 2003 Q3 | 977 Million USD | 0.31% |
| 2003 Q4 | 1.17 Billion USD | 19.96% |
| 2003 Q1 | 826 Million USD | -2.48% |
| 2002 Q3 | 840 Million USD | 0.6% |
| 2002 Q4 | 847 Million USD | 0.83% |
| 2002 Q1 | 909 Million USD | -6.58% |
| 2002 Q2 | 835 Million USD | -8.14% |
| 2002 FY | 847 Million USD | -12.95% |
| 2001 Q2 | 568 Million USD | 0.0% |
| 2001 Q1 | 568 Million USD | -1.05% |
| 2001 Q3 | 859 Million USD | 51.23% |
| 2001 Q4 | 973 Million USD | 13.27% |
| 2001 FY | 973 Million USD | 69.51% |
| 2000 FY | 574 Million USD | -15.34% |
| 2000 Q2 | 567 Million USD | -0.53% |
| 2000 Q1 | 570 Million USD | -15.93% |
| 2000 Q4 | 574 Million USD | 1.41% |
| 2000 Q3 | 566 Million USD | -0.18% |
| 1999 Q1 | 1.26 Billion USD | -7.61% |
| 1999 Q3 | 761 Million USD | -28.21% |
| 1999 Q4 | 678 Million USD | -10.91% |
| 1999 FY | 678 Million USD | -50.29% |
| 1999 Q2 | 1.06 Billion USD | -15.87% |
| 1998 Q4 | 1.36 Billion USD | 146.22% |
| 1998 FY | 1.36 Billion USD | 2845.57% |
| 1998 Q1 | 554.9 Million USD | 1098.49% |
| 1998 Q2 | 551.2 Million USD | -0.67% |
| 1998 Q3 | 553.9 Million USD | 0.49% |
| 1997 Q3 | 49.9 Million USD | 0.0% |
| 1997 Q4 | 46.3 Million USD | -7.21% |
| 1997 FY | 46.3 Million USD | -1.91% |
| 1997 Q1 | 47.2 Million USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1996 Q4 | 47.2 Million USD | 0.0% |
| 1996 FY | 47.2 Million USD | 263.08% |
| 1996 Q1 | - USD | -100.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q4 | 13 Million USD | 42.86% |
| 1995 Q3 | 9.1 Million USD | 0.0% |
| 1995 Q2 | 9.1 Million USD | -1.09% |
| 1995 FY | 13 Million USD | 46.07% |
| 1995 Q1 | 9.2 Million USD | 3.37% |
| 1994 FY | 8.9 Million USD | 48.33% |
| 1994 Q4 | 8.9 Million USD | 0.0% |
| 1994 Q3 | 8.9 Million USD | 0.0% |
| 1994 Q2 | 8.9 Million USD | 48.33% |
| 1994 Q1 | 6 Million USD | 0.0% |
| 1993 Q1 | 6.1 Million USD | 0.0% |
| 1993 Q2 | 6.1 Million USD | 0.0% |
| 1993 FY | 6 Million USD | -1.64% |
| 1993 Q4 | 6 Million USD | 0.0% |
| 1993 Q3 | 6 Million USD | -1.64% |
| 1992 Q1 | 23.2 Million USD | 8.41% |
| 1992 Q3 | 6.4 Million USD | -72.65% |
| 1992 Q4 | 6.1 Million USD | -4.69% |
| 1992 FY | 6.1 Million USD | -71.5% |
| 1992 Q2 | 23.4 Million USD | 0.86% |
| 1991 Q4 | 21.4 Million USD | 0.0% |
| 1991 FY | 21.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| aap Implantate AG | 3.46 Million EUR | -258291.003% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | -3377.151% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | -3377.151% |
| elexxion AG | 4076.67 EUR | -219811658.126% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 47.35 Million EUR | -18822.629% |
| Geratherm Medical AG | 7.23 Million EUR | -123825.66% |
| Koninklijke Philips N.V. | 6.95 Billion EUR | -28.769% |
| Stratec SE | 80.8 Million EUR | -10990.347% |
| Siemens Healthineers AG | 436 Million EUR | -1955.275% |